@FierceMedDev: U.S. regulators are worried about an off-label use of stents or balloons to treat MS. More | Follow @FierceMedDev
@MarkHFierce: CareFusion acquires a Brazilian respiratory company. More | Follow @MarkHFierce
@DamianFierce: Olympus Biotech is tossing its hat into the CMO ring. More | Follow @DamianFierce
> Insurers are trying to recover more of the healthcare-related costs associated with medical device failures from the device companies themselves. Story
> St. Jude Medical ($STJ) unveiled new technology designed to help evaluate vascular and cardiac conditions on a recorded fluoroscopic image instead of live fluoroscopy, with a goal of reducing radiation exposure. Release
> The FDA has signed off on Dexcom's ($DXCM) new continuous glucose monitoring system, which is designed to be much more accurate in determining when patients are hypoglycemic. Release
> Boston Scientific ($BSX) will release its 2012 third-quarter results Oct. 18. Release
> Xconomy's Luke Timmerman says San Francisco is the clear No. 1 biotech hub, but Boston is hot on its heels. Article
> Researchers from Austria and Germany believe a nanotechnology material, made, in part, from licorice could help better sterilize medical devices and implants. Release
Biotech News
@FierceBiotech: ACRO decries TV portrayal of clinical. More | Follow @FierceBiotech
@JohnCFierce: Honey, we shrunk the biotech: Targacept cuts back (again). Release | Follow @JohnCFierce
@RyanMFierce: Life Technologies bought a bioinformatics group, Compendia, a U of Mich. spinoff. Terms undisclosed. More | Follow @RyanMFierce
> Stem cell pioneers win this year's Nobel prize for medicine. Story
> AstraZeneca bags PhIIb-ready CKD drug in $272M Ardelyx partnership. Article
> Troubled Targacept whacks laboratory ops in latest restructuring. News
Pharma News
@FiercePharma: A head-scratcher for SEC: Pfizer reports U.S. loss, $15B in overseas profits. More | Follow @FiercePharma
> Novartis CEO: No on megadeals, yes on dividend. Story
> Novo exec welcomes the Bristol-AZ diabetes blitz. Article
CRO News
> Quintiles looks to Scotland for clinical trial growth. Article
> Icon partners with Korean CRO group. More
> Catalent, Parexel team up for trial supply. News
> Olympus Biotech jumps into CMO game. Story
Biotech IT News
> Oracle, IBM support $100M personalized medicine effort at UPMC. Article
> Biotech billionaire's supercomputer cuts cancer analysis to 47 seconds. Story
> 'Big Data' startup wins deal with Aptalis Pharma. More